Description
FLT3 inhibitors after allogeneic haematopoietic stem cell transplantation in paediatric AML
Article: FLT3 inhibitors after allogeneic haematopoietic stem cell transplantation in paediatric AML
€3.03
Related products
-
Article: Calendar of events
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Calendar of events
€3.03 Add to cart -
Article: Highlights in breast cancer
€3.03 Add to cart
